Pyxis Oncology Prices Public Offering of Common Stock, Warrants

03:58 AM EDT, 09/30/2026 (MT Newswires) -- Pyxis Oncology (PYXS) has priced a public offering of common stock and warrants for expected gross proceeds of about $110 million, the company said Wednesday. The offering includes 36.05 million common shares, or pre-funded warrants in lieu of 1.88 million shares for certain investors, and accompanying warrants to purchase 49.31 million common shares at $3.50 each, Pyxis Oncology said. The combined offering price is $2.90 per share and warrant, or $2.899 per pre-funded warrant and warrant, the company said. Net proceeds will be used to advance its lead clinical program, working capital, and general corporate purposes, Pyxis Oncology said. The offering is expected to close around Thursday.